PLAT-E Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Plat-E (Platinum-E) is a retrovirus packaging cell line engineered from the human embryonic kidney 293T cell background. It was developed to provide a stable and efficient system for transient production of high-titer, ecotropic retroviruses. The cell line was constructed using novel packaging constructs in which the expression of viral structural genes - gag-pol and env - is driven by the human EF1α promoter, which is substantially more potent in 293T cells than the conventional MuLV long terminal repeat (LTR) promoter. This design ensures robust transcriptional activity and supports high-level production of viral components necessary for efficient retrovirus assembly and packaging. Plat-E cells were generated through sequential stable transfection of pEnv-IRES-puror and pGag-pol-IRES-bsr constructs, which link the viral genes to antibiotic resistance markers via internal ribosome entry sites (IRES). This configuration guarantees that only cells expressing the essential viral genes also gain antibiotic resistance, allowing for selection of high-expressing subclones. The resulting Plat-E line consistently produces retroviruses with titers up to 1 × 107 infectious units per milliliter for at least four months when cultured under dual selection with puromycin and blasticidin. Northern blot, reverse transcriptase activity, and flow cytometry analyses confirmed that Plat-E exhibits significantly higher gag-pol and env expression than predecessor packaging lines such as Bosc23 and Phoenix-E. Plat-E’s architecture minimizes the risk of generating replication-competent retrovirus (RCR) by limiting the packaging constructs to only the necessary coding regions of the viral structural genes and separating them onto different plasmids. This design requires at least three recombination events to produce RCR, thereby enhancing biosafety. Plat-E has proven useful in gene transfer applications, including efficient transduction of primary cells such as T cells and mast cells. Its performance and long-term stability make it a reliable platform for retroviral vector production in both basic research and preclinical gene therapy development. |
|---|---|
| Organism | Human |
| Tissue | Fetal kidney |
| Synonyms | Platinum-E |
Characteristics
| Age | Fetus |
|---|---|
| Gender | Female |
| Growth properties | Adherent |
Regulatory Data
| Citation | PLAT-E (Cytion catalog number 305855) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_B488 |
| GMO Status | GMO-S1: This retroviral packaging cell line (PLAT-E) contains constructs encoding gag-pol and env under EF1α promoter control, supporting production of ecotropic retroviral particles. The modifications are stably present in HEK293T-derived cells. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Mutational profile |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Seeding density | 1 to 4 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305855-240226 | Certificate of Analysis | 27. Mar. 2026 | 305855 |